Standout Papers

The 2014 International Society of Uro... 1998 2026 2007 2016 2.1k
  1. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma (2015)
    Jonathan I. Epstein, Lars Egevad et al. The American Journal of Surgical Pathology
  2. The World Health Organization/International Society of Urological Pathology Consensus Classification of Urothelial (Transitional Cell) Neoplasms of the Urinary Bladder (1998)
    Jonathan I. Epstein, Mahul B. Amin et al. The American Journal of Surgical Pathology
  3. A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score (2015)
    Jonathan I. Epstein, Michael J. Zeléfsky et al. European Urology
  4. LONG-TERM BIOCHEMICAL DISEASE-FREE AND CANCER-SPECIFIC SURVIVAL FOLLOWING ANATOMIC RADICAL RETROPUBIC PROSTATECTOMY (2001)
    Misop Han, Alan W. Partin et al. Urologic Clinics of North America
  5. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium (2001)
    Alan W. Partin, Leslie A. Mangold et al. Urology
  6. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia (2013)
    John R. Srigley, Brett Delahunt et al. The American Journal of Surgical Pathology
  7. Proliferative Inflammatory Atrophy of the Prostate (1999)
    Angelo M. De Marzo, Valérie Marchi et al. American Journal Of Pathology
  8. Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis. (1994)
    Ronald A. Morton, Jonathan I. Epstein et al. Proceedings of the National Academy of Sciences
  9. Correlation of pathologic findings with progression after radical retropubic prostatectomy (1993)
    Jonathan I. Epstein, Galina Pizov et al. Cancer
  10. Biochemical (Prostate Specific Antigen) Recurrence Probability Following Radical Prostatectomy for Clinically Localized Prostate Cancer (2003)
    Misop Han, Alan W. Partin et al. The Journal of Urology
  11. Biochemical (Prostate Specific Antigen) Recurrence Probability Following Radical Prostatectomy for Clinically Localized Prostate Cancer (2003)
    Misop Han, Alan W. Partin et al. The Journal of Urology
  12. Cancer Control and Quality of Life Following Anatomical Radical Retropubic Prostatectomy: Results at 10 Years (1994)
    Patrick C. Walsh, Alan W. Partin et al. The Journal of Urology
  13. Prostate Specific Antigen in the Staging of Localized Prostate Cancer: Influence of Tumor Differentiation, Tumor Volume and Benign Hyperplasia (1990)
    Alan W. Partin, H. Ballentine Carter et al. The Journal of Urology
  14. Active Surveillance Program for Prostate Cancer: An Update of the Johns Hopkins Experience (2011)
    Jeffrey J. Tosoian, Bruce J. Trock et al. Journal of Clinical Oncology
  15. PROSTATE-SPECIFIC ANTIGEN AFTER ANATOMIC RADICAL RETROPUBIC PROSTATECTOMY (1997)
    Charles R. Pound, Alan W. Partin et al. Urologic Clinics of North America
  16. Prostate Specific Antigen in the Preoperative and Postoperative Evaluation of Localized Prostatic Cancer Treated with Radical Prostatectomy (1988)
    Joseph E. Oesterling, Daniel W. Chan et al. The Journal of Urology
  17. Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. (1993)
    Alan W. Partin, Charles R. Pound et al. PubMed
  18. Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary Grades (2012)
    Jonathan I. Epstein, Zhaoyong Feng et al. European Urology
  19. Prediction of Progression Following Radical Prostatectomy (1996)
    Jonathan I. Epstein, Alan W. Partin et al. The American Journal of Surgical Pathology
  20. Prognostic G leason grade grouping: data based on the modified G leason scoring system (2013)
    Phillip M. Pierorazio, Patrick C. Walsh et al. British Journal of Urology
  21. Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation (2014)
    Jonathan I. Epstein, Mahul B. Amin et al. The American Journal of Surgical Pathology
  22. An Update of the Gleason Grading System (2009)
    Jonathan I. Epstein The Journal of Urology
  23. Intermediate and Longer-Term Outcomes From a Prospective Active-Surveillance Program for Favorable-Risk Prostate Cancer (2015)
    Jeffrey J. Tosoian, Mufaddal Mamawala et al. Journal of Clinical Oncology
  24. Positive Surgical Margins After Radical Prostatectomy: A Systematic Review and Contemporary Update (2013)
    Ofer Yossepowitch, Alberto Briganti et al. European Urology
  25. Genomic and phenotypic heterogeneity in prostate cancer (2020)
    Michael C. Haffner, Wilbert Zwart et al. Nature Reviews Urology

Immediate Impact

4 by Nobel laureates 10 from Science/Nature 82 standout
Sub-graph 1 of 21

Citing Papers

Pan-cancer whole-genome comparison of primary and metastatic solid tumours
2023 StandoutNature
Current best practice for bladder cancer: a narrative review of diagnostics and treatments
2022 Standout
6 intermediate papers

Works of Jonathan I. Epstein being referenced

Correlation of cystoscopic impression with histologic diagnosis of biopsy specimens of the bladder
2001
The World Health Organization/International Society of Urological Pathology Consensus Classification of Urothelial (Transitional Cell) Neoplasms of the Urinary Bladder
1998 Standout
and 34 more

Author Peers

Author Last Decade Papers Cites
Jonathan I. Epstein 45885 16383 15480 977 62.0k
Peter T. Scardino 39907 10430 9899 737 50.9k
Peter R. Carroll 30126 6099 9987 870 44.9k
Alan W. Partin 30367 7759 6273 643 39.3k
Francesco Montorsi 32046 11052 17503 1.7k 57.7k
Patrick C. Walsh 28931 9236 7799 576 39.8k
Theodorus van der Kwast 21602 4942 8092 647 34.4k
Victor E. Reuter 23668 3719 12113 503 40.5k
Shahrokh F. Shariat 21177 3781 36853 1.6k 56.7k
Michael L. Blute 27910 3711 9531 502 35.5k
Peter L. Choyke 31579 6387 5848 1.1k 62.4k

All Works

Loading papers...

Rankless by CCL
2026